A 2005 phase-3 clinical trial called "SAINT-1" reported some efficacy in the acute treatment of ischemia injury due to stroke.
The 2005 phase-3 clinical trial named "SAINT-1" demonstrated some effectiveness in the treatment of acute stroke ischemia injury.